Pharmabiz31m
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr: San Francisco Saturday, January 18, 2025, 09:00 Hrs [IS ...
Pharmabiz1h
FIEO to host power talk ‘SME in Focus’ for SMEs in pharma sector in Hyderabad on January 24
FIEO to host power talk ‘SME in Focus’ for SMEs in pharma sector in Hyderabad on January 24: Shardul Nautiyal, Mumbai Saturday, January 18, 2025, 08:00 Hrs [IST] The Federatio ...
Pharmabiz1h
DGFT issues new SOP for voluntary disclosure of SCOMET violations to bolster India’s pharma export control framework
Shardul Nautiyal, Mumbai Saturday, January 18, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Kerala govt creates 250 posts of pharmacists under dept of health & family welfare, appointment to start soon
Kerala govt creates 250 posts of pharmacists under dept of health & family welfare, appointment to start soon: Peethaambaran Kunnathoor, Chennai Saturday, January 18, 2025, 08:00 ...
Pharmabiz1h
NPPA asks manufacturers to submit data on certain dosage forms of nicotine to fix ceiling prices
Gireesh Babu, New Delhi Saturday, January 18, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Orthopaedics sector on the cusp of a transformative era driven by technological solutions: Sushant Banerji
Orthopaedics sector on the cusp of a transformative era driven by technological solutions: Sushant Banerji: Shardul Nautiyal, Mumbai Saturday, January 18, 2025, 08:00 Hrs [IST] Th ...
Pharmabiz1h
Indian pharma hopes for policy-level clarifications & simplifying APA procedures in Union Budget 2025
Indian pharma hopes for policy-level clarifications & simplifying APA procedures in Union Budget 2025: Nandita Vijayasimha, Bengaluru Saturday, January 18, 2025, 08:00 Hrs [IST] I ...
Pharmabiz2d
Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm
Chugai Pharmaceutical Co., Ltd. and Cheplapharm K.K. announced that Chugai will transfer the business in Japan concerning the anti-cancer agent Tarceva tablets 25, 100, and 150 to Cheplapharm. Chugai ...
Pharmabiz2d
THE JAN VISHWAS ACT
The Indian Parliament had passed the Jan Vishwas (Amendment of Provisions) Bill, 2023 to remove stringent punishments such as imprisonment from some of the provisions of the Drugs and Cosmetics Act, ...
Pharmabiz2d
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy
Takeda, a global leader in biopharmaceutical innovation, has inaugurated its flagship Global Innovation Capability Centre (ICC). The Takeda India ICC is a part of Takeda’s Data, Digital & Technology ...
Pharmabiz2d
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2
New findings from the National Institutes of Health’s (NIH) Researching Covid to Enhance Recovery (RECOVER) Initiative suggest that infection with SARS-CoV-2, the virus that causes Covid-19, may be ...
Pharmabiz2d
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company, announces that the Scottish Medicines Consortium (SMC) has published recommendations that Agamree (vamorolone) is accepted for use ...